SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049169
Filing Date
2024-04-26
Accepted
2024-04-26 16:19:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A for_filing_2024_defa14a.htm DEFA14A 42504
2 GRAPHIC img179917491_0.jpg GRAPHIC 93138
3 GRAPHIC img179917491_1.jpg GRAPHIC 52834
  Complete submission text file 0000950170-24-049169.txt   244885
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39527 | Film No.: 24884071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)